Nanoscope Therapeutics Receives Orphan Drug Designation for gene therapy of blindness

BEDFORD, Texas, Jan. 25, 2021 /PRNewswire/ -- NANOSCOPE THERAPEUTICS Inc., a clinical-stage biotechnology company determined to change lives through the ocular gene therapy, today…